Beam Therapeutics Inc. (BEAM) Operating cash flow 2019–2025
Beam Therapeutics Inc. (BEAM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$345.1MFY2025 · since FY2019: -$72.0M → -$345.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$345.1M | +0.6% |
| FY2024 | -$347.2M | -132.7% |
| FY2023 | -$149.2M | -762.3% |
| FY2022 | $22.5M | +134.0% |
| FY2021 | -$66.3M | +30.8% |
| FY2020 | -$95.7M | -33.0% |
| FY2019 | -$72.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice